Nicolaides

TL3 Regular · Palermo, IT

Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.

Joined 11 December 2024 · last posted 2d · groups: analytical-chemists

163 posts, newest first. Showing up to 150.

Irish differences from the UK position — what changed since Replied, post #12 · Regional › UK & Ireland · 26 Jul 2026 · 4 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed. It is…
Retatrutide mass and identity: what a report should show Replied, post #26 · Compounds › Retatrutide · 25 Jul 2026 · 0 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
Why the Start Here categories exist, and what they are not for Replied, post #35 · Start Here › Welcome · 25 Jul 2026 · 28 likes What would change my mind on Start is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #80 · Practice › Interactions · 23 Jul 2026 · 24 likes I read the earlier replies on Antibiotics twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said…
Request: a per-category review queue Replied, post #121 · Meta › Feature requests · 22 Jul 2026 · 2 likes I have no financial interest in anything named in this thread and I want to say so before I comment on per-category review queue, because it is the sort of subject…
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #23 · Clinical › Bloodwork · 21 Jul 2026 · 19 likes Everything in post #19 holds. The case it does not cover is the one I have. Reframing egfr fluctuation slightly, because I think the disagreement is about the question…
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #19 · Clinical › Bloodwork · 19 Jul 2026 · 0 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. This is the version I would want a new…
Tracking intake honestly when appetite is absent Replied, post #104 · Nutrition & Training › Protein & intake · 18 Jul 2026 · 0 likes Tracking intake sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
Pooling trials with different estimands Replied, post #107 · Evidence › Meta-analyses · 18 Jul 2026 · 27 likes Worth separating two things that post #104 runs together. If you are new and reading this thread for the answer to pooling trials with different estimands: the answer…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #96 · Practice › Administration · 16 Jul 2026 · 0 likes Subcutaneous injection into abdominal tissue, thigh or upper arm is what the licensed labelling in this class describes, and the published comparisons found the…
Which categories are strict and which are relaxed, honestly Replied, post #17 · Start Here › Welcome · 15 Jul 2026 · 26 likes One thing that took me a while to notice: the search box indexes maintained documents as well as topics, and documents carry a review date. If a document and a…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #102 · Compounds › Semaglutide · 12 Jul 2026 · 32 likes Post #101 is right about the mechanism and I think understates the practical bit. Counterpoint on semaglutide and gastric emptying, offered without confidence: the same…
What a reversed-phase purity number actually is Replied, post #20 · Analytics › HPLC & UHPLC · 3 Jul 2026 · 14 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #32 · Pharmacology › Receptor biology · 1 Jul 2026 · 0 likes I read post #28 twice before replying, because I had assumed the opposite. Receptor desensitisation came up in a thread eighteen months ago and was answered well. I…
I joined for one answer and stayed for a year — what changed my mind Replied, post #52 · Start Here › Welcome · 30 Jun 2026 · 11 likes The answer to the reading-order question is: the how-to-ask page, then whichever compound page applies to you, then the sourcing standard. Forty minutes and it saves…
Electrolyte supplements: which ones do anything Replied, post #41 · Nutrition & Training › Hydration & electrolytes · 27 Jun 2026 · 31 likes Nothing here is medical advice and electrolyte questions in the context of a genuine deficit belong with a clinician rather than a forum.
Personal or family history of medullary thyroid carcinoma Replied, post #13 · Safety › Contraindications · 25 Jun 2026 · 32 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either.
Carryover and the ghost peak from last week's standard — what changed since Replied, post #58 · Analytics › HPLC & UHPLC · 22 Jun 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
[2026 update] Waist circumference technique and its repeatability Replied, post #18 · Outcomes › Progress reports · 20 Jun 2026 · 0 likes Adding a small correction to the Waist circumference technique summary above rather than a disagreement with it. The substance holds; one of the figures is out by a…
What I would want from a home test that does not exist yet — what changed since Replied, post #57 · Analytics › Home & field testing · 16 Jun 2026 · 10 likes Coming back to post #55, because the follow-up matters more than the original answer. Where home testing is genuinely valuable is as a screen before spending on…
Insurance and replacement policies, compared Replied, post #18 · Sourcing › Logistics · 13 Jun 2026 · 32 likes Trying to state the insurance and replacement policies position in a way that someone who disagrees would recognise as fair, because I do not think the version in this…
Follow-up: Reading an interaction checker output critically Replied, post #2 · marked as the solution · Practice › Interactions · 10 Jun 2026 · 30 likes This follows the opening post rather than contradicting it. I disagree with the framing of Reading an interaction checker output above, and I think it is a substantive…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #75 · Practice › Administration · 8 Jun 2026 · 0 likes That is a cleaner way of putting what I was circling around.
What a good consultation looks like from the other side Replied, post #46 · Clinical › Prescriber conversations · 2 Jun 2026 · 18 likes Genuine question rather than a rhetorical one: has anyone here actually observed good consultation, as opposed to read about it? The thread is long and I cannot tell.
Official shortage notices and what they authorise Replied, post #80 · Access › Shortages · 1 Jun 2026 · 0 likes Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing.
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #31 · Practice › Storage & stability · 31 May 2026 · 4 likes Temperature excursions in transit are common and are not all equal. A few hours warm is a different event from three days warm, and neither is visible in the vial on…
Blind submission and why it changes minds — the long version Replied, post #109 · Sourcing › Independent verification · 31 May 2026 · 0 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.
A supplier who responds to a discrepancy with silence — what changed since Replied, post #52 · Sourcing › Red flags · 25 May 2026 · 0 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
[2026 update] What a good consultation looks like from the other side Replied, post #33 · Clinical › Prescriber conversations · 24 May 2026 · 22 likes This follows post #30 rather than contradicting it. Careful with the language on good consultation. "Not detected" and "not present" are different findings and the…
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #15 · Start Here › How to Ask · 22 May 2026 · 4 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
GLP-1 receptor distribution: central and peripheral Replied, post #49 · Pharmacology › Receptor biology · 14 May 2026 · 0 likes Confirming post #48 from a second method, which matters more than confirming it from a second person. The area postrema sits outside the blood-brain barrier and is…
Chain of custody for a sample you posted yourself — one year on Replied, post #18 · Sourcing › Independent verification · 12 May 2026 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #52 · Compounds › Repair & healing peptides · 11 May 2026 · 3 likes That is the distinction I keep failing to hold on to. Written down now.
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #5 · Compounds › Semaglutide · 11 May 2026 · 16 likes Where I part company with the opening post, and it is a narrow parting. Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management…
Naming conventions for research peptides and the confusion they cause Replied, post #2 · Compounds › Other compounds · 9 May 2026 · 19 likes The failure mode on naming conventions for research peptides is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #111 · Compounds › Tirzepatide · 5 May 2026 · 3 likes Coming back to post #109, because the follow-up matters more than the original answer. Categorical response thresholds — the proportion reaching ten, fifteen or twenty…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #58 · Data & Tools › Datasets · 29 Apr 2026 · 12 likes Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed. Newer data is more current.
The anatomy of a question that gets answered within an hour Replied, post #30 · Start Here › How to Ask · 28 Apr 2026 · 16 likes Picking up post #27: that is the part I would want checked first. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
An appeal that succeeded, with the letter structure Started this topic · Access › Insurance & coverage · 23 Apr 2026 · 25 likes On the subject in the title: An appeal that succeeded, with the letter structure Working notes rather than a conclusion. Appeal, and specifically the version of it that…
Sample handling between despatch and injection Replied, post #38 · Analytics › Method validation · 13 Apr 2026 · 4 likes Where I part company with post #34, and it is a narrow parting. Where the sample handling between despatch discussion usually stalls is that nobody wants to say "I do…
Second pass at: What pooling buys you and what it destroys Replied, post #37 · Evidence › Meta-analyses · 12 Apr 2026 · 6 likes Good question, well framed, and I would like to see it answered properly.
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #3 · Practice › Reconstitution · 8 Apr 2026 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
Follow-up: State-level differences that actually matter Replied, post #62 · Regional › North America · 7 Apr 2026 · 12 likes Building on post #59 rather than restating it. I have been on both sides of the State-level differences argument in this category within eighteen months, which should…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #100 · Clinical › Special populations · 6 Apr 2026 · 6 likes Adding the measurement that post #97 says would settle it. The documentation on pregnancy and pregnancy planning is better than this thread and I say that as someone…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #47 · Data & Tools › Datasets · 5 Apr 2026 · 28 likes Adding the measurement that post #45 says would settle it. Version the file rather than editing in place. A dataset that changes silently under an analysis makes the…
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #20 · Practice › Administration · 18 Mar 2026 · 15 likes Useful. I had the fact and not the reason, which turns out to be the important half.
An ABAB design with a data table and honest limitations — a second dataset Replied, post #43 · Research Methods › N-of-1 designs · 7 Mar 2026 · 0 likes Small methodological point on ABAB design: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
The lowest dose that does anything: is that a real question? Replied, post #6 · Practice › Dosing & titration · 1 Mar 2026 · 32 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
Second pass at: The topic list is dense — is that deliberate? Replied, post #84 · Meta › Site feedback · 27 Feb 2026 · 5 likes Feedback on the trust-level page: it explains what each level unlocks, and not what a member at that level is expected to do differently. The second is what people…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #93 · Pharmacology › Pharmacokinetics · 27 Feb 2026 · 2 likes Post #92 is right about the mechanism and I think understates the practical bit. Washout after stopping takes roughly the same four to five half-lives as reaching…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #42 · Analytics › Impurities & related substances · 25 Feb 2026 · 25 likes Post #38 and I disagree about the size of the effect, not about the direction. Aggregates: multiples of the monomer mass. May not elute at all under a standard…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #46 · Practice › Dosing & titration · 17 Feb 2026 · 0 likes Taking post #43 at face value and following it one step further. If you are stepping up mainly because the schedule says so rather than because the current dose has…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #44 · Pharmacology › Pharmacokinetics · 16 Feb 2026 · 6 likes Second this, and I would have said it less carefully.
Five questions in one post gets you one answer — how to split them Replied, post #13 · Start Here › How to Ask · 15 Feb 2026 · 18 likes A methods point on five questions rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
Request declined, with reasoning — what changed since Replied, post #12 · Meta › Feature requests · 11 Feb 2026 · 3 likes Fair. Then under the name, at a smaller size, permanently. It is worth stating the boring hypothesis before the interesting one.
Trifluoroacetate content and its consequences Replied, post #121 · Analytics › Impurities & related substances · 10 Feb 2026 · 10 likes Picking up post #120: that is the part I would want checked first. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #69 · Clinical › Bloodwork · 5 Feb 2026 · 0 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
Preprint servers and what screening they do Replied, post #44 · Evidence › Preprints · 3 Feb 2026 · 0 likes Post #41 is the version of this I will quote in future. One addition. A preprint reporting a null result is more likely to stay a preprint, which biases the published…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #50 · Clinical › Special populations · 23 Jan 2026 · 28 likes Narrowing post #47, because the general version has more than one answer. Being outside the studied population does not mean a treatment is unsafe. It means the usual…
[2026 update] What a purity-only report leaves out Replied, post #5 · Sourcing › Independent verification · 20 Jan 2026 · 0 likes On purity-only I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads…
Coverage in the US: a map of the usual obstacles Replied, post #35 · Regional › North America · 12 Jan 2026 · 26 likes Pharmacy practice varies between pharmacies within the same city, so two honest accounts can be entirely different. If that reads as pedantic, it is, and it has saved…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #79 · Practice › Side effects · 11 Jan 2026 · 8 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Heterogeneity as information rather than as a nuisance Replied, post #58 · Evidence › Meta-analyses · 11 Jan 2026 · 1 like Confirming post #56 from a second method, which matters more than confirming it from a second person. The claim about heterogeneity upthread is stronger than its source…
A partial dose because the pen emptied mid-injection Replied, post #10 · Practice › Administration · 7 Jan 2026 · 0 likes Narrowing post #9, because the general version has more than one answer. The single most common technique error described here is drawing to the wrong graduation…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #42 · Pharmacology › Receptor biology · 4 Jan 2026 · 8 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
The most useful thing you learned here that was not the answer you came for Replied, post #12 · Lounge › Off topic · 4 Jan 2026 · 10 likes This is the sort of exchange that makes the archive worth searching.
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #27 · Compounds › Retatrutide · 30 Dec 2025 · 27 likes The phase 3 programme is ongoing and its results will change what can be said here. Until then, this subcategory's convention is to state the phase alongside any result…
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #13 · Start Here › Welcome · 22 Dec 2025 · 0 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #108 · Practice › Reconstitution · 28 Nov 2025 · 4 likes Building on post #107 rather than restating it. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into…
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #53 · Analytics › Impurities & related substances · 25 Nov 2025 · 2 likes Coming back to post #49, because the follow-up matters more than the original answer. Aggregates may be a multiple of the monomer mass and may not elute at all under a…
Documentation that appears only after payment Replied, post #83 · Sourcing › Red flags · 21 Nov 2025 · 18 likes Coming back to post #79, because the follow-up matters more than the original answer. A stock listing that never changes and a lead time that never varies are both…
Prescription requirements and telehealth models Replied, post #8 · Sourcing › Regulatory · 10 Nov 2025 · 14 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post. I have changed my…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #32 · Compounds › Semaglutide · 8 Nov 2025 · 6 likes Post #28 and I disagree about the size of the effect, not about the direction. Semaglutide solutions: I have looked for the primary source twice and failed twice.…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #20 · Practice › Side effects · 8 Nov 2025 · 13 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Personal import allowances, compared — a second dataset Replied, post #16 · Access › International · 31 Oct 2025 · 23 likes Counterpoint on Personal import allowances, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull…
Sleep quality changes during weight loss — what changed since Replied, post #43 · Wellbeing › Sleep · 29 Oct 2025 · 12 likes Post #39 put the caveat in the right place and I want to underline it. Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep.…
Publishing an inconvenient result: a case study — the long version Replied, post #21 · Sourcing › Independent verification · 28 Oct 2025 · 8 likes No disagreement from me. Posting only so the question does not look ignored.
Follow-up: What a seizure notice actually says Replied, post #42 · Sourcing › Logistics · 28 Oct 2025 · 11 likes Worth separating two things that post #38 runs together. Seizure notice looks different depending on whether you are reading the primary literature or the summaries of…
Reading SURMOUNT-1 without the press release — one year on Replied, post #17 · Compounds › Tirzepatide · 26 Oct 2025 · 0 likes Taking post #16 at face value and following it one step further. On storage: published stability data covers the licensed formulation at its licensed concentration. A…
A parcel that arrived warm: a decision process, not a verdict Replied, post #86 · Practice › Storage & stability · 15 Oct 2025 · 30 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
Documentation that materially improves an appeal's chances Replied, post #25 · Access › Insurance & coverage · 11 Oct 2025 · 15 likes The denial letter is the specification for your appeal. It states a criterion, and the job is to demonstrate that the criterion is met in the letter's own language. Not…
Particulates in a reconstituted solution: identifying the likely source Replied, post #12 · Analytics › Impurities & related substances · 7 Oct 2025 · 0 likes Building on post #9 rather than restating it. Having read the whole particulates thread before replying: the question in the first post has not actually been answered…
Why oral semaglutide needs an absorption enhancer at all Replied, post #38 · Compounds › Oral incretins · 3 Oct 2025 · 0 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #40 · Compounds › Tirzepatide · 15 Sep 2025 · 0 likes The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual. Most trials in this space compare one or two doses against…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #51 · Practice › Side effects · 10 Sep 2025 · 20 likes This follows post #49 rather than contradicting it. Source for the nausea timeline figure, since it was asked for. It is in the discussion rather than the abstract,…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #18 · Data & Tools › Datasets · 6 Sep 2025 · 9 likes Limitations of datasets: all community-collected data has limitations. The population is self-selected (people in this community are not representative of all people…
Column chemistry choices for a 40-residue peptide Replied, post #29 · Analytics › HPLC & UHPLC · 5 Sep 2025 · 0 likes An update on my earlier column chemistry choices post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Coming back to: What published stability data actually covers, and what it does not Replied, post #125 · Practice › Storage & stability · 28 Aug 2025 · 28 likes This follows post #124 rather than contradicting it. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #67 · Clinical › Special populations · 25 Aug 2025 · 0 likes Post-surgical populations, particularly after procedures affecting the gastrointestinal tract, interact with a delayed-emptying mechanism in ways that need specialist…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #111 · Compounds › Repair & healing peptides · 22 Aug 2025 · 0 likes Dose-response is unstudied in humans for essentially everything in this family, which means the confident numbers in circulation came from somewhere other than a trial.
[2026 update] Cold solution and stinging: the simplest fix Replied, post #10 · Practice › Administration · 20 Aug 2025 · 10 likes I came in to disagree and I am leaving without a disagreement.
EU-wide position versus national implementation — what changed since Started this topic · Regional › European Union · 16 Aug 2025 · 1 like EU-wide position versus national implementation — what changed since Writing it up because I had to work it out twice and would rather nobody else did. What changes if…
A request that was declined, and the reasoning — a second dataset Replied, post #81 · Documentation › Wiki requests · 14 Aug 2025 · 21 likes Where a request is for a translation or a regional version, the maintenance burden doubles and the proposal should say who carries it. Written quickly, so the reasoning…
A request that was declined, and the reasoning — a second dataset Replied, post #72 · Documentation › Wiki requests · 13 Aug 2025 · 18 likes That matches what I have seen, for whatever a single anecdote is worth.
When a preprint is the best available evidence and we say so Replied, post #50 · Evidence › Preprints · 12 Aug 2025 · 24 likes Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight.
Thyroid function tests during substantial weight change Replied, post #27 · Clinical › Bloodwork · 11 Aug 2025 · 1 like Thyroid function tests during substantial looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not…
Tracking that stops updating and then resumes — the long version Replied, post #4 · Sourcing › Logistics · 9 Aug 2025 · 8 likes The arithmetic in post #3 is right; the assumption feeding it is the part to check. Import restrictions by jurisdiction: what is legal to import for personal use varies…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #107 · Wellbeing › Mental health · 9 Aug 2025 · 7 likes One more thing on history of disordered eating that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that,…
Research-use-only labelling: what it means and what it does not Replied, post #20 · Sourcing › Regulatory · 9 Aug 2025 · 2 likes My experience of research-use-only labelling contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience…
Travel coolers and how long they really hold Replied, post #9 · Devices › Cold chain · 31 Jul 2025 · 9 likes A parcel sitting in a vehicle or a depot in a hot month is the excursion that matters and the one nobody sees. Delivery timing is part of the cold chain. If it helps:…
Canadian access and provincial variation — one year on Replied, post #37 · Regional › North America · 27 Jul 2025 · 0 likes Canadian access and provincial variation is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with…
Follow-up: Why appetite effects are mostly central Replied, post #5 · Pharmacology › Receptor biology · 24 Jul 2025 · 14 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #75 · Clinical › Comorbidities · 20 Jul 2025 · 7 likes Age at the extremes of the studied range is an extrapolation in both directions, and the trials generally studied a narrower band than the discussion assumes. The…
Coming back to: An 18-month record including the parts that went badly Replied, post #82 · Outcomes › Progress reports · 19 Jul 2025 · 3 likes If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that is the useful finding. That has held every time I have looked, which is not…
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #9 · Practice › Storage & stability · 18 Jul 2025 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
Counter-ion content and its effect on measured mass Replied, post #71 · Analytics › Mass spectrometry · 22 Jun 2025 · 7 likes Post #70 and I disagree about the size of the effect, not about the direction. Combining a chromatographic result with a mass result is genuinely orthogonal…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #53 · Pharmacology › Pharmacokinetics · 19 Jun 2025 · 0 likes Clearance pathways would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #58 · Evidence › Journal club · 16 Jun 2025 · 24 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #24 · Evidence › Trials · 10 Jun 2025 · 6 likes Everything in post #20 holds. The case it does not cover is the one I have. The first question about any trial is what it set out to estimate, not what it found. Once…
[2026 update] An appeal that failed, and what I would do differently Replied, post #45 · Access › Insurance & coverage · 9 Jun 2025 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #43 · Evidence › Trials · 2 Jun 2025 · 6 likes A trial that answers a slightly different question from the one you have is the normal situation rather than a failure of the trial. The skill is describing the gap…
Sequence verification for an obscure compound: how it is done Replied, post #47 · Compounds › Other compounds · 28 May 2025 · 1 like Post #43 describes the usual case. This is about the unusual one. A compound with no established assay is a compound where a certificate can say almost anything. That…
Which panel is worth repeating and which is worth ignoring Replied, post #26 · Clinical › Bloodwork · 26 May 2025 · 4 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #58 · Compounds › Other compounds · 25 May 2025 · 2 likes Useful. I have added it to my own notes with the date on it.
Water content on a certificate and why it changes the arithmetic Replied, post #24 · Analytics › COA interpretation · 17 May 2025 · 1 like A certificate is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is not nothing.…
Shakes versus food: a pragmatic assessment — the long version Replied, post #27 · Nutrition & Training › Protein & intake · 17 May 2025 · 33 likes Post #24 answers the question as asked. The question underneath it is different. Nothing here is medical or dietetic advice, and a dietitian is the professional this…
A claim built entirely on a subgroup analysis Replied, post #34 · Evidence › Study critique · 14 May 2025 · 7 likes Reporting bias within a paper — a result in a figure that is absent from the abstract — is checkable and is worth checking when the claim matters. Correct me on the…
Lean mass preservation: what the evidence supports Replied, post #15 · Outcomes › Body composition · 14 May 2025 · 10 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
Regression to the mean in progress reports Replied, post #9 · Research Methods › Statistics · 13 May 2025 · 0 likes Reading this regression thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #3 · Practice › Reconstitution · 8 May 2025 · 9 likes This is the sort of exchange that makes the archive worth searching.
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #8 · Compounds › Repair & healing peptides · 5 May 2025 · 1 like The practical version of TB-500 and thymosin beta-4 is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
Reading order for a first week here, and what to skip until later Replied, post #110 · Start Here › Welcome · 1 May 2025 · 26 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Subcutaneous absorption kinetics and site differences Started this topic · Pharmacology › Pharmacokinetics · 28 Apr 2025 · 0 likes Posting this under the heading it deserves: Subcutaneous absorption kinetics and site differences Everything below is what sits behind that. Asking about subcutaneous…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #116 · Evidence › Journal club · 22 Apr 2025 · 6 likes STEP 1 looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
When to suspect the method rather than the sample Replied, post #110 · Analytics › Method validation · 6 Apr 2025 · 8 likes This follows post #109 rather than contradicting it. Specificity: the method can distinguish the intended compound from related impurities and degradation products.…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #72 · Practice › Reconstitution · 6 Apr 2025 · 0 likes Building on post #69 rather than restating it. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #81 · Sourcing › Vendor reports · 17 Mar 2025 · 3 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.
One lot is one lot: when a report becomes a pattern — the long version Replied, post #62 · Sourcing › Vendor reports · 16 Mar 2025 · 9 likes Include the sample handling: how it was stored, how it travelled to the laboratory, how long it sat. A result on badly handled material is measuring the handling. Old…
Validating a method you did not develop — does this still hold? Replied, post #124 · Analytics › Method validation · 16 Mar 2025 · 11 likes Specificity is the first question: does the method separate the analyte from everything reasonably expected to be present? A method that has not been challenged with…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #116 · Compounds › Other compounds · 16 Mar 2025 · 0 likes What would change my mind on Research-use-only status is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would…
When "no data" is the complete and final answer Replied, post #112 · Compounds › Other compounds · 8 Mar 2025 · 3 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #99 · Sourcing › Regulatory · 6 Mar 2025 · 22 likes Agreed, and I will stop repeating the version of this I had been repeating.
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #8 · Practice › Interactions · 6 Mar 2025 · 2 likes Taking delayed gastric emptying and oral seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #44 · Sourcing › Regulatory · 1 Mar 2025 · 0 likes If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category.
Pharmaceutical compounding rules, summarised from primary sources Replied, post #35 · Sourcing › Regulatory · 1 Mar 2025 · 1 like Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so.
Validating a method you did not develop — does this still hold? Replied, post #35 · Analytics › Method validation · 22 Feb 2025 · 19 likes A method that reports the same number for every lot is worth a second look. Real processes vary, and a total absence of variation is a statement about the measurement…
Distinguishing a deletion sequence by mass alone Replied, post #105 · Analytics › Mass spectrometry · 19 Feb 2025 · 0 likes Confirming post #104 from a second method, which matters more than confirming it from a second person. An acylated peptide has a mass that reflects the modification, so…
What we do not know about retatrutide, listed explicitly Replied, post #95 · Compounds › Retatrutide · 13 Feb 2025 · 5 likes This follows post #92 rather than contradicting it. Anyone deciding on the basis of what is published should know that what is published is a phase 2 programme and some…
Scheduled maintenance and what will be unavailable Replied, post #41 · Meta › Announcements · 12 Feb 2025 · 15 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
Consistent declarations and why they matter more than clever ones Replied, post #8 · Sourcing › Logistics · 8 Feb 2025 · 0 likes The documentation on consistent declarations is better than this thread and I say that as someone who has posted in the thread.
Checking someone else's arithmetic: a worked example thread Replied, post #20 · Practice › Reconstitution · 7 Feb 2025 · 14 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. This is where…
Follow-up: What other technical communities get right that we do not Replied, post #11 · Lounge › Off topic · 5 Feb 2025 · 11 likes Adding a data point of agreement rather than a data point.
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #15 · Access › International · 27 Jan 2025 · 19 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #29 · Documentation › Doc review · 26 Jan 2025 · 18 likes Ask what the page would look like if it were wrong. A document with no stated failure conditions is hard to review and harder to maintain.
Follow-up: What this community means by "a source", in practical terms Replied, post #21 · Start Here › Welcome · 15 Jan 2025 · 26 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #5 · Analytics › COA interpretation · 14 Jan 2025 · 7 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
A promotion I argued against, and why I lost Replied, post #53 · Documentation › Doc review · 7 Jan 2025 · 13 likes I had written a reply contradicting post #49 and deleted it. Here is what survived. For anyone finding this later: the short answer on promotion is that it depends on…
Oxidation pathways for methionine and tryptophan Replied, post #34 · Analytics › Impurities & related substances · 28 Dec 2024 · 15 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #18 · Evidence › Journal club · 24 Dec 2024 · 25 likes An hour is enough for one paper read properly and not enough for two read partly. The temptation is always to add the second. I would want a second opinion before…
[2026 update] New subcategory: rationale and scope Replied, post #90 · Meta › Announcements · 24 Dec 2024 · 16 likes The rare case here is the one that costs somebody a week, though, and the common case costs everyone ten seconds. I think the trade is clearly correct. Correct me on…